Skip to content
← Full study record

NCT00073918 · MORE INFO

Limitations, agreements, and source contact

Iodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma · Source last updated 2017-08-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
agopal@u.washington.edu
organization
Fred Hutchinson Cancer Research Center
phone
206-288-2037
title
Ajay K. Gopal, MD
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
agopal@u.washington.edu
organization
Fred Hutchinson Cancer Research Center
phone
206-288-2037
title
Ajay K. Gopal, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice